Literature DB >> 15339901

Systolic hypertension in older persons.

Sarwat I Chaudhry1, Harlan M Krumholz, JoAnne Micale Foody.   

Abstract

CONTEXT: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure emphasizes the importance of systolic hypertension (SH), defined as systolic blood pressure (SBP) of at least 140 mm Hg and diastolic blood pressure of less than 90 mm Hg, in older persons (> or =60 years).
OBJECTIVE: To systematically review the literature on clinical management of SH in older persons. DATA SOURCES: We performed a MEDLINE search of English-language literature from 1966-2004 to identify reports about SH in older persons, with particular emphasis on data from randomized clinical trials. STUDY SELECTION AND DATA EXTRACTION: We selected 1064 studies by using the search terms hypertension combined with the terms systole (or systolic) and aged. DATA SYNTHESIS: There is strong evidence from clinical trials to support the treatment of SH in older persons with SBP of at least 160 mm Hg. Large-scale trials to assess the value of antihypertensive therapy for older patients with SBP of 140 to 159 mm Hg have not been performed, and recommendations to treat these patients are based on observational studies that show a graded relationship of cardiovascular risk with increasing SBP. The studies most strongly support the use of thiazide diuretics and long-acting calcium channel blockers as first-line therapy to treat SH.
CONCLUSIONS: Treatment of SH in older patients with SBP of at least 160 mm Hg is supported by strong evidence. The evidence available to support treatment of patients to the level of 140 mm Hg or those with baseline SBP of 140 to 159 mm Hg is less strong; thus, these treatment decisions should be more sensitive to patient preferences and tolerance of therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339901     DOI: 10.1001/jama.292.9.1074

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  25 in total

1.  Does Clinical Inertia Vary According to Provider Type?

Authors:  Daniel G Federman; Kirsha S Gordon; Joseph Goulet; Sue Kancir; Woody Levin; Shawn L Fultz; Amy C Justice
Journal:  Fed Pract       Date:  2008

2.  Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study.

Authors:  Carmen A Peralta; Mary A Whooley; Joachim H Ix; Michael G Shlipak
Journal:  Am J Hypertens       Date:  2006-09       Impact factor: 2.689

Review 3.  Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges.

Authors:  Jennifer G Robinson
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 4.  2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations.

Authors:  Lawrence R Krakoff; Robert L Gillespie; Keith C Ferdinand; Icilma V Fergus; Ola Akinboboye; Kim A Williams; Mary Norine Walsh; C Noel Bairey Merz; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2014-07-29       Impact factor: 24.094

5.  Personality and health in middle age as predictors for well-being and health in old age.

Authors:  Pasqualina Perrig-Chiello; Susanne M Jaeggi; Martin Buschkuehl; Hannes B Stähelin; Walter J Perrig
Journal:  Eur J Ageing       Date:  2008-12-09

6.  Views of older adults on patient participation in medication-related decision making.

Authors:  Vernee N Belcher; Terri R Fried; Joseph V Agostini; Mary E Tinetti
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

7.  Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.

Authors:  Jennifer G Robinson; Catherine Rahilly-Tierney; Elizabeth Lawler; J Michael Gaziano
Journal:  J Clin Lipidol       Date:  2011-11-07       Impact factor: 4.766

8.  Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes.

Authors:  Mary E Tinetti; Gail J McAvay; Terri R Fried; Heather G Allore; Joanna C Salmon; Joanne M Foody; Luann Bianco; Sandra Ginter; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

9.  Combination therapy in hypertension: An update.

Authors:  Sanjay Kalra; Bharti Kalra; Navneet Agrawal
Journal:  Diabetol Metab Syndr       Date:  2010-06-24       Impact factor: 3.320

10.  Nature or nurture; BMI and blood pressure at 90. Findings from the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST).

Authors:  I Maeve Rea; Phyo K Myint; Heiko Mueller; Anne Murphy; G Pooler R Archbold; Helene McNulty; Chris C Patterson
Journal:  Age (Dordr)       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.